Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 410, 115363
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 46 references indexed in Scilit:
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survivalJournal of Oral Pathology & Medicine, 2011
- Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (II)Oral Oncology, 2010
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repairProceedings of the National Academy of Sciences, 2010
- Clinical Studies of Histone Deacetylase InhibitorsClinical Cancer Research, 2009
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapyCancer Letters, 2008
- Acetylation Is Indispensable for p53 ActivationCell, 2008
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Valproic Acid, an Antiepileptic Drug with Histone Deacetylase Inhibitory Activity, Potentiates the Cytotoxic Effect of Apo2L/TRAIL on Cultured Thoracic Cancer Cells through Mitochondria-Dependent Caspase ActivationNeoplasia, 2006